These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 18855271

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M, Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini L.
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial.
    Tahir M, Foley B, Pate G, Crean P, Moore D, McCarroll N, Walsh M.
    Am Heart J; 2005 Aug; 150(2):302-6. PubMed ID: 16086935
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study].
    Rosolová H, Cech F, Sefrna F.
    Vnitr Lek; 2002 Aug; 48(8):701-6. PubMed ID: 12425199
    [Abstract] [Full Text] [Related]

  • 28. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z, Umnerová V, Heller S, Peleska J, Jindra A, Jáchymová M, Kvasnicka J, Horký K, Aschermann M.
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [Abstract] [Full Text] [Related]

  • 29. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G, Chello M, Pasceri V, Colonna D, Nusca A, Miglionico M, D'Ambrosio A, Covino E, Di Sciascio G.
    J Am Coll Cardiol; 2006 Oct 17; 48(8):1560-6. PubMed ID: 17045888
    [Abstract] [Full Text] [Related]

  • 30. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
    Lambertucci L, Di Serio C, Castellani S, Torrini M, Lotti E, Cristofari C, Masotti G, Marchionni N, Ungar A.
    Transl Res; 2011 Jun 17; 157(6):348-56. PubMed ID: 21575919
    [Abstract] [Full Text] [Related]

  • 31. Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus.
    Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, Iwasaka T.
    Thromb Res; 2006 Jun 17; 117(4):385-92. PubMed ID: 15896827
    [Abstract] [Full Text] [Related]

  • 32. The fixed combination of verapamil SR/trandolapril.
    Widimský J.
    Expert Opin Pharmacother; 2000 Mar 17; 1(3):515-35. PubMed ID: 11249535
    [Abstract] [Full Text] [Related]

  • 33. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
    Katayama S, Kawamori R, Iwamoto Y, Saito I, Kuramoto K, ATTEST Study Group.
    Hypertens Res; 2008 Aug 17; 31(8):1499-508. PubMed ID: 18971523
    [Abstract] [Full Text] [Related]

  • 34. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N, Puri D, Madhu SV, Sharma SB.
    QJM; 2008 Jun 17; 101(6):449-55. PubMed ID: 18385148
    [Abstract] [Full Text] [Related]

  • 35. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
    Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T.
    Thromb Res; 2005 Jun 17; 115(4):277-85. PubMed ID: 15668187
    [Abstract] [Full Text] [Related]

  • 36. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
    Nomura S, Inami N, Kimura Y, Omoto S, Shouzu A, Nishikawa M, Iwasaka T.
    J Hum Hypertens; 2007 Jan 17; 21(1):38-44. PubMed ID: 17051237
    [Abstract] [Full Text] [Related]

  • 37. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2008 May 17; 76(1):52-6. PubMed ID: 18474381
    [Abstract] [Full Text] [Related]

  • 38. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB, Curran MP, Perry CM.
    Drugs; 2002 May 17; 62(17):2539-67. PubMed ID: 12421112
    [Abstract] [Full Text] [Related]

  • 39. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study GroupCattedra di Medicina Interna, Università di Milano, Ospedale S. Gerardo, Italy..
    Am J Hypertens; 1997 May 17; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [Abstract] [Full Text] [Related]

  • 40. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J, Oficjalska-Młyńczak J.
    Przegl Lek; 2007 May 17; 64(6):389-92. PubMed ID: 18159844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.